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INTRODUCTION 
Encephalitis is an inflammatory disorder of the brain parenchyma manifesting 
with neurological dysfunction. It is usually caused by infectious agents, mostly by 
viruses. The neurological dysfunction can be: cognitive dysfuntion (e.g. acute 
memory loss, speech disturbance), mental change (disorientation, hallucination, 
psychosis, personality change, agitation), focal deficit, seizures. 
The diagnosis is based on the clinical picture, and is supported by modern 
investigations such as MRI or microbiological diagnostics. All these however, cannot 
replace the experienced clinician who has to decide on treatment and make rational 
plans of diagnostic workup.  
The inflammation of the brain parenchyma can be the result of direct infection 
(infectious encephalitis, IE ), of a postinfectious, immune-mediated process (acute 
disseminated encephalomyelitis, ADEM ), may manifest as paraneoplastic 
syndrome, or is - rarely - caused by other immune mechanisms. Though clinical 
picture is similar in most cases, the above pathomechanisms are worth to be 
differentiated in favour of appropriate treatment.  
The pathomechanism  of a neuroinfection is the result of a complex interaction 
between the infectious agent and host cells. Most viruses reach the nervous system 
by haematogenous whilst others (rabies virus, some herpes viruses) mainly by neural 
spread. The arboviruses are inoculated in the skin by arthropods (tick, mosquito), 
then they invade and infect the nervous system by the bloodstream.  
The viruses can lead to neurological symptoms either by direct damaging of 
neurons or by influencing neuronal functions via modification of the host immune 
mechanisms. The spectrum of neurological signs and symptoms depends on 
neurovirulence and neurotropism of the virus on one hand and on host immune 
response on the other.  
Some viruses cause a disease via immune mechanisms (ADEM). 
Limbic encephalitis (LE)  is the result of an immune process, too. First it was 
taken solely to a paraneoplastic syndrome, based on the immunological similarity of 
certain tumour antigens and neural cells. The majority of the paediatric cases 
however, are non-paraneoplastic. 
IE is most often caused by viruses, less often by other microorganisms . The 
infectious agent is dependent of geographical region, climate, vaccinations and of the 
occurrence and density of vectors. Most of them may cause disease in anyone, while 
some agents - certain herpes viruses, the JC virus (JCV), Toxoplasma gondii – result 
in neuroinfection primarily of immunocompromised hosts. 
Most ADEM cases are preceded by upper respiratory or enteric infections of 
unidentified origin, or – rarely – by immunizations.  
The incidence  of encephalitis is 1.9-7.4 per 100 000, being 1.27/100 000 
inhabitants per year in Hungary in 2009. It is more frequent in children. ADEM 
represents 2 to15% of all acute encephalitides. 
IE is preceded in most cases by unspecific symptoms (prodroma ) such as 
malaise, loss of appetite, chills, nausea, vomiting, abdominal pain, diarrhoea, 
headache, cough, rash, joint or muscle pain. A biphasic course is typical of 
enteroviruses (EV) and the tick-borne encephalitis (TBE) virus: the febrile prodroma 
is followed by an afebrile period lasting a couple of days, then neurological symptoms 
develop with concurrent fever. The peculiarities of the prodroma may help identifying 
the microorganism. In ADEM the medical literature rather uses the term preceding 
event (that triggers immune mechanisms) instead of “prodroma”. This occurs in a half 
to one third of cases. Neurological symptoms follow in 2 to 30 days. 
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Encephalitis is typically a triad of fever, headache and disturbed 
consciousness/mental change  that may be accompanied by seizures and focal 
deficits . Motor dysfunction  (palsy, extrapyramidal movement disorder, tremor) 
occurs in a quarter of cases, but ataxia , cranial nerve signs and speech 
disturbance may be present, too. The autonomic nervous system,  the 
hypothalamus  may also be involved. Intracranial hypertension can develop. Some 
microorganisms result in specific neurological symptoms. Focal or multifocal 
neurological symptoms and encephalopathy preceded within 30 days by viral 
infection or immunization is typical of ADEM.  
AERRPS (acute encephalitis with repetitive refractory partial seizures) was first 
described in 1989. Its diagnostic criteria: an acute phase lasting for at least 2 weeks, 
repetitive, refractory, similar partial seizures with frequently occurring status 
epilepticus from the acute phase to convalescence, and lack of a specific etiology.  
EEG is a sensitive indicator of cerebral function. It is usually abnormal early and 
shows episodic or continuous, focal or generalized slow activity with or without 
epileptic discharges. It is rarely typical of the underlying pathogen however, in one 
third to a half of herpes simplex virus (HSV) encephalitis (HSE) cases periodic 
lateralized epileptic discharges (PLED) can be seen.  
MRI is highly sensitive even in the early stage. It should be carried out in the 
presence of focal deficits, severe or progressive symptoms! It is also useful in 
excluding other conditions. The MRI abnormalities may refer to the pathogenic role of 
certain microorganisms. In the first days of ADEM MRI can be normal however, later 
it becomes abnormal in 100% of cases: focal or multifocal, ill-defined hyperintense 
lesions of irregular shape are seen in the brain and often in the spinal cord. 
Radiological follow-up is indispensable, and complete or partial resolution of lesions 
is seen within 3 to 6 months in ADEM. In LE areas of increased T2 signal are found 
in the hippocampi and amygdalae, sometimes also in the hypothalamus and the 
striatum. 
CSF cell count is mildly elevated in more than half of both IE and ADEM 
cases. First granulocytes, whereas later lymphocytes predominate. Red blood cells 
are found in the CSF of approx. 20% of cases, especially in HSE. CSF protein is 
increased in a quarter, while IgG/albumin ratio in 25-50% of cases. A normal CSF 
does not exclude encephalitis!  
Microbiological investigations should be rationally tailored upon 
epidemiological data, immunological and vaccination status of the patient as well as 
on clinical, radiological and EEG findings. A definite microbiological diagnosis relies 
upon the detection of the pathogen in central nervous system sample. Investigation 
of any other sample (throat or nasal swab, blood, faeces) can make the pathogen 
probable. Evaluation of serological tests  needs caution and experience. Some 
microbes are diagnosed upon specific IgM found in the serum. The detection of 
seroconversion is often time-consuming but very important from the point of view of 
retrospective diagnosis. The specific IgM against some viruses can be detected in 
the CSF, too. Polimerase chain reaction (PCR ) has become part of the routine 
diagnostics. PCR examination of the CSF has replaced brain biopsy in diagnosing 
HSE. PCR positivity is most likely detected on day 4 to 7 of symptoms when the virus 
temporarily enters the CSF space. It is worth to use both PCR and serology. Viral 
culture is labor-intensive and time-consuming but often of diagnostic value in cases 
of enteroviral (EV) etiology.  
Specific treatment is necessary in HSE, and it comes up in encephalitides 
caused by other viruses, Mycoplasma pneumoniae or other bacteriae. High-dose 
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methylprednisolone pulse therapy as well as plasma exchange or high-dose 
intravenous immunoglobulin are regarded as causal treatment in ADEM. 
To alleviate intracranial hypertension mannitol and furosemide can be 
administered, mechanical hyperventilation and – in case of imminent herniation - 
decompressive craniectomy may be undertaken. Phenytoin or other anticonvulsants 
can be given to stop or prevent seizures. Respiration, circulation and fluid 
balance  has to be monitored and supported. Thrombosis  of the deep veins, 
disseminated intravascular coagulation, aspiration pneumonia, secondary 
bacterial infections and gastrointestinal bleedings  are to be avoided.  
With the wide-spread use of measles-mumps-rubella vaccination  
encephalitides caused by these viruses have become preventable. Immunisation can 
prevent further diseases such as TBE, varicella-encephalitis, rotavirus 
encephalopathy, rabies or japanese encephalitis. 
Prognosis  depends on the pathogen, the host immune status, the symptoms 
and on whether a specific treatment is available. 69-90% of patients recover with 
minimal or no sequelae. Postencephalitis epilepsy (PE)  develops in as much as 
16% of patients or in a larger proportion of those having seizures in the acute stage. 
Hippocampal sclerosis resulting in mesial temporal lobe epilepsy may in part be 
related to viral encephalitis. The shorter the latency of developing PE, the less 
favourable is its outcome. PE patients often have cognitive deficit. Motor 
dysfunction  is expected in 4-40%, cognitive and/or behaviour disturbance – 
depending on the testing method – in 4-50% of ADEM patients, whereas the risk of 
multiple deficits  is 9%. 
Relapses  are not typical of IE however, they are known to occur in HSE. New 
demyelination event occurs in 8-30% of ADEM patients and it can be either recurrent 
ADEM, multiphasic ADEM or multiple sclerosis.  
The mortality rate of encephalitis is 1 to 12%. 
 
AIMS OF THE PRESENT STUDY 
I was seeking answers to the following questions: 
• What is the frequency and outcome of childhood encephalitis in the leading 
infectious diseases hospital of Hungary? 
• What is the frequency of IE and ADEM, respectively? 
• What is the morbidity and mortality of encephalitis? 
• What are the differences between the clinical picture and the outcome of IE 
and ADEM? 
• In what proportion of cases can a microbiological diagnosis be verified? 
• What is the frequency of certain microorganisms? 
• Do clinical, electrophysiological, radiological findings and outcome differ 
according to the underlying pathogens? 
• How do clinical, electrophysiological and radiological findings influence the 
outcome? 
• What are our findings like compared to literature data? 
 
PATIENTS AND METHODS 
I analysed data of patients less than 18 years of age treated for encephalitis 
between 1998 and 2009 at the Departments of Paediatrics, Paediatric Intensive 
Care, Paediatric Haematology and Bone Marrow Transplantation and Paediatric 
Neurology Outpatient Service of Szent László Hospital, Budapest.  
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To diagnose encephalitis I simultaneously used criteria proposed by several 
authors if conditions resulting in similar clinical picture could be excluded. I 
established the diagnosis of encephalitis, if ≥1 of the following  signs revealing 
dysfunction of the brain parenchyma was present: encephalopathy, seizure(s), 
paresis, ataxia, plus ≥2 of the following : fever, abnormal CSF findings, 
microbiological proof of infection, abnormal EEG, CT or MRI typical of encephalitis. 
I personally took case histories of all patients. In the majority of them the first 
neurological exam was also done by myself. I documented epidemiological, clinical 
data, results of complementary investigations and followed-up the patients after their 
discharge for as long as I could.  
Microbiological tests were performed in the Microbiological Labs of Szent László 
Hospital and of the National Centre of Epidemiology, respectively. 
Immunofluorescent assays (IFA) for HSV and EV were routinely performed from both 
serum and CSF samples, as was HSV PCR from 2003 onwards and viral culture 
from CSF, throat swab and faeces until 2008. When clinically suspected serum and 
CSF IFA for adenovirus, Epstein-Barr virus (EBV), varicella-zoster virus (VZV), 
parainfluenzavirus (PIV), TBEV as well as complement fixation test for Mycoplasma 
pneumoniae, influenza viruses, ELISA (enzyme-linked immunosorbent assay) for 
cytomegalovirus (CMV), and – in immunocompromised patients - multiple PCR for 
the following microbes were undertaken: HSV1-2, VZV, EBV, CMV, human 
herpesvirus 6 (HHV6), Toxoplasma gondii, JCV. At one patient with cerebral 
toxoplasmosis PCR had to be done on brain biopsy specimen, too. When rotavirus 
encephalopathy was suspected, antigen test from faeces was performed. 
I established the definite pathogenic role of a microorganism if  
• encephalitis was in relation with a prodroma obviously attributed to that 
microbe (varicella, rotavirus enteritis, leptospirosis), 
• specific antibodies were detected both in serum and CSF, 
• the pathogen could either be cultured or detected by PCR from the CSF, 
• the pathogen could be detected in biopsied central nervous system tissue. 
I established the probable pathogenic role of a microorganism if  
• an acute neurological syndrome followed exanthema subitum (HHV6), 
• specific antibodies were solely detected in serum, but either IgM and/or IgA 
revealing recent infection were present or a 4-fold rise in the titre of specific 
IgG was found in the convalescent sample, 
• the pathogen could be cultured or detected by PCR from extraneural sample 
(throat swab or faeces) but not from the CSF. 
EEG recordings were made by a 16-channel computerised equipment of the 
Szent László Hospital EEG Lab, or at the Paediatric Intensive Care Department by a 
16-channel computerised, portable device. All recordings were analysed according to 
uniform regards.  
Abnormal EEG changes were classified as follows: mild to moderate diffuse 
dysfunction, severe diffuse dysfunction, focal change, paroxysmal sign, periodicity 
(PLED). 
Cranial CT  scans were performed at Heim Pál Children’s Hospital, at Szent 
István Hospital or in the referring institute. Cranial and spinal MRIs were carried out 
by 1,0 and 1,5 T MR devices of Budapest MÁV Hospital, National Institute of 
Psychiatry and Neurology, Szent István Hospital, Semmelweis University Central 
Radiology Diagnostics, respectively; whereas from May 2006 onwards by the 3,0 T 
equipment of Semmelweis University MR Research Centre. I reviewed all images, 
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and if my opinion differed from that of the radiologist, I proposed personal discussion 
or consulted with a neuroradiologist.  
Absolute and relative frequencies of data concerning qualitative clinical 
characteristics and neuroimaging were estimated. The majority of continuous 
variables (e.g. hospital days, laboratory parameters) are of non-normal distribution, 
thus their medians and quartiles, in some instances the min-max. values are given. 
Statistical comparisons were made in these cases by the Mann-Whitney probe. 
Comparison of qualitative data was done by the chi-square and z-probe, or – in case 
of low frequencies – by the Fisher’s exact-test. Statistical comparisons were 
performed by two-sided probes on p<0.05 significance level, whereas at multiple 
comparisons, to make significance level more strict, the Bonferroni method was 
applied. The role of the analysed clinical, laboratory and radiological attributes in the 
outcome of the disease was examined by uni- or multivariate logistic regression. The 
odds ratio (OR), the 95% confidence interval (95%CI) and the significance level is 
communicated. In case of multivariate logistic regression the stepwise (forward) 
method was also used. 
 
RESULTS 
In the 12-year-period 178 children were treated at Szent László Hospital for 179 
encephalitis episodes . This represented 0.2% of the patient turnover of the 
Paediatric, while 5% of that of the Paediatric Intensive Care Department. 47% of all 
children communicated with encephalitis in Hungary  were treated at our hospital.  
3 patients were immunocompromised. The median age of patients was 7 y, the ratio 
of infants and toddlers was 12 and 12%, respectively. The ratio of boys was 57%. 
103 patients (57%) required intensive care .  
85% of patients had IE, 13% had ADEM. 3 patients (1 LE, 2 Kawasaki 
syndrome) had a different immune mechanism in the background.  
In 68% of cases related to infection (IE and ADEM) the infectious agent was 
found definite (40%) or probable (28%) . 16% of the verified pathogens was HSV, 
38% was EV, 11% was VZV, 7 and 7% were TBEV and adenovirus, respectively. 
There were cases related to rotavirus, EBV, CMV, HHV6, influenza A virus, PIV, 
JCV, T. gondii, M. pn., Leptospira and diphtheria-pertussis-tetanus vaccine.  
Special diseases:  In a 14-y-o girl the clinical picture corresponded to AERRPS 
(acute encephalitis with refractory, repetitive partial seizures), a severe syndrome of 
unknown pathomechanism however, EV-specific IgM, IgA and increasing amount of 
IgG was detected in her serum. A 9-y-o boy was diagnosed with devastating 
epileptic encephalopathy in school-aged children (D ESC). Three patients had 
LE. In 2 of them causative role of HSV was proved, in 1 case no etiology was found 
in the acute stage, but later she developed an autoimmune disease (SLE). An 
adolescent AIDS patient had progressive multifocal leukoencephalopathy (PML). 
Four children had bilateral striatal laesion  (BSL), a peculiar form of ADEM, where 
both clinically and radiologically bilateral involvement of the striatum predominates: 
cessation of verbal communication, negativism, whining cry, extrapyramidal rigor, 
sometimes dystonia is present. In 3 of these cases etiological role of varicella was 
proven. An adolescent girl with adenovirus encephalitis developed reversible lesion 
in the callosal splenium, which corresponded to the clinical and radiological entity of 
mild encephalitis/encephalopathy with a reversible splenial lesion  (MERS) 
described in 2004 bay japanese authors. 
In 65% of patients (more often in ADEM) neurological symptoms were preceded 
or followed by a prodroma . In ADEM focal deficits, confusion and severe disturbance 
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of consciousness were more common than in IE. Seizures occurred more often in 
encephalitis caused by HSV than by other pathogens. Paresis, pyramidal signs, 
speech disturbance and ataxia were more typical of VZV. 
While “routine” testing of the CSF (protein, glucose and cell count) was 
abnormal in 72%, the examination with estimation of protein ratios was abnormal in 
85% of patients. Peripheral blood WBC and IgG/albumin ratio was significantly higher 
in ADEM as compared to IE, which may reflect more marked systemic inflammation 
and intrathecal humoral immune reaction. CSF protein was significantly higher in 
HSE as compared to EV encephalitis. 
EEG was abnormal in 93% of cases. Severe diffuse dysfunction occurred more 
often in ADEM than in IE. Seven of the 8 patients showing periodic EEG changes 
(PLED) had HSE, and PIV was the pathogen in one. Only 35% of HSE cases had 
PLED. Both focal, paroxysmal changes and PLEDs were more common in HSE than 
in cases of other etiologies. 
Central nervous system imaging (echography, CT or MRI) was performed in 
77% of patients. Cranial CT scan was abnormal in 41 of 93 cases (44%), whereas 
MRI showed abnormalities in 61 of 96 (63%). CT was followed by MRI in 56 patients, 
and proved abnormal after a normal CT scan in 24 (43%)! MRI more often showed 
pathologies in patients who had multiple seizures. CT scan was abnormal in 50 while 
the MRI in 96% of ADEM cases. These proportions were 44 and 53% for IE. I found 
significant differences so between ADEM and IE as among the most frequent 3 
pathogens (EV, HSV, TBE) in regard to certain MR abnormalities.  
58% of all and 79% of ADEM patients required intensive care . The median 
duration of it was 11 while that of the overall hospital stay was 13 days. In ADEM 
patients these were 17 and 24 days, respectively. There was a higher likelihood of an 
HSV patient to require intensive care and for a longer duration, in contrast to patients 
with EV, VZV or TBE encephalitis. 
Acyclovir treatment  was administered in 47% of patients - for a median of 9 
days and for a median of 20 days in patients with proven HSE. The 2 patients with 
toxoplasmosis were given clindamycin, sulfadiazin, pyrimethamin and co-trimoxazol. 
High-dose methylprednisolone pulse therapy was applied in 22 cases; besides 
ADEM patients one with LE and – of different considerations - 6 IE patients. 3 ADEM 
patients responded unsatisfactorily to methylprednisolone, thus in them plasma 
exchange was added. High-dose intravenous immunoglobulin (IVIG) was given to 5 
children (2 with Kawasaki disease, 1 with AERRPS, 1 with encephalitis+Guillain-
Barré syndrome and 1 with ADEM). Medical dehydration with mannitol or/and 
furosemide was used in 134 (75%). In 4 patients decompressive craniectomy was 
also carried out and was life saving in one. 43 patients (24%) were given – often 
combined - anticonvulsive therapy. Occipital lobe resection was performed because 
of intractable seizures in the girl with AERRPS, unfortunately with no effect. 60 
patients (33%, or 58% of those requiring intensive care) needed mechanical 
ventilation, for a median of 7 days. Respiratory insufficiency was more likely in cases 
with HSV etiology, severely disturbed consciousness, seizures, severe dysfunction, 
paroxysmal and periodic changes of the EEG and abnormal MRI. Mechanical 
ventilation was of significantly longer duration in cases with focal and/or periodic EEG 
changes, abnormal MRI and CSF result. 
Mortality  was 3% (6 patients). Of the surviving 172 I could follow-up 169 
patients. 71% of patients completely recovered .  
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Sequelae (26%) occurred more often after ADEM than after IE, following 
severely disturbed consciousness, seizure(s), severe diffuse dysfunction, focal, 
paroxysmal and periodic changes of the EEG and abnormal MRI.  
Motor dysfunction  (8%) was more likely following HSE, while severe motor 
dysfunction occurred more often in patients less than one year of age, in those with 
repeated seizures, focal, paroxysmal EEG signs or abnormal MRI. 
Cognitive dysfunction  (20%) was more frequent after ADEM and HSE, severe 
disturbance of consciousness, seizure(s), or when WBC was less than 10,0 G/L, CSF 
protein was increased or the MRI was abnormal. Patients under 1 year of age, those 
without focal deficits, with multiple seizures, focal or paroxysmal EEG changes were 
more prone to moderate to severe cognitive dysfunction.  
The median latency of developing epilepsy  (14%) was 78 days and 
postencephalitic epilepsy (PE) was more likely to be severe after shorter latency. PE 
occurred more often in case of acute seizure(s), severely disturbed consciousness, 
WBC lower than 10,0 G/L, severe diffuse dysfunction, focal and paroxysmal EEG 
changes. PE was more likely to be severe in patients less than 1 year of age, those 
with HSV etiology and focal deficits. 
Multiple handicap (11%) was more frequent following HSV etiology, in patients 
less than one year old, in those with severely disturbed consciousness, WBC less 
than 10,0 G/L, repeated seizures, severe dysfunction, focal, paroxysmal and periodic 
EEG changes or abnormal MRI. 
Relapses  occurred in 2 ADEM patients (1 multiphasic ADEM, 1 multiple 
sclerosis) and in 1 infant with HSV encephalitis.  
The most important predictors of unfavourable outcome (sequelae and death) 
were: immune pathomechanism (ADEM), HSV etiology, severe disturbance of 
consciousness, focal seizures, paresis, pyramidal signs, WBC<10,0 G/L, paroxysmal 
EEG changes, cortical, subcortical abnormal signal on MRI. 
 
SUMMARY OF THE MOST IMPORTANT RESULTS 
1. Combining recommendations of several authors I introduced unified criteria 
to establish the diagnosis of encephalitis. 
2. In the study period of 12 years I saw a high number of encephalitic 
children,  approximately one half of the patients communicated throughout the 
country. The majority of patients could be followed-up. Complex clinical, 
epidemiological, electropysiological and radiological analysis of such a high 
number of encephalitic children has not been carried out in Hungary before.   
2.1. 2% of our patients were immunocompromised. 
2.2. 85% of cases were of infectious (IE), whereas 15% were of immune 
pathomechanism. 
3. The infectious cause or trigger could be verified or made likely in two 
thirds  of cases: a high proportion even compared to international data.  
3.1. 38% of these were enterovirus, what is very high compared to 
international data and may be a local particularity. 
3.2. In the ADEM group the participation of varicella-zoster virus (VZV) as a 
trigger was outstanding - 25%. 
4. I have diagnosed some special conditions :  
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4.1. The ADEM cases related to varicella included 3 children whose clinical 
picture corresponded to bilateral striatal laesion (BSL). The likely causal 
relationship between this peculiar clinico-radiological entity and varicella 
has been first described by me. 
4.2. I diagnosed acute encephalitis with refractory, repetitive partial seizures 
(AERRPS) in a 14-y-o girl. According to serological tests enterovirus might 
have had an etiological role.  
4.3. I established and published progressive multifocal leukoencephalopathy 
(PML) in an adolescent AIDS patient.  
4.4. I diagnosed the rare syndrome of mild encephalitis/encephalopathy with 
a reversible splenial lesion (MERS) in an adolescent girl with adenovirus-
encephalitis.  
4.5. So the presence and characteristics of the prodroma as the general 
signs are incapable to differentiate between IE and ADEM however, 
confusion, severe disturbance of consciousness and some focal deficits 
are more typical of ADEM than of IE. 
5. Clinical signs typical of certain microbes: seizures rather characterize HSV 
and EV encephalitis, whereas paresis, pyramidal tract signs, speech 
disturbance and ataxia are more common in VZV encephalitis. 
6. Adding IgG/albumin ratio to “routine” CSF testing decreased “negative CSF 
results” to nearly the half.  
7. WBC and IgG/albumin ratio was higher in ADEM  than in IE. 
8. I introduced MRI in routine workup of more severe cases, relying upon which 
both immune therapy of ADEM and antiviral treatment of HSE is started at an 
earlier stage.  
9. More than half of the patients required intensive c are, especially ADEM 
and HSE patients. 
10. Risk factors of respiratory insufficiency were HSV etiology, abnormal MRI, 
certain EEG changes particularly periodicity. ADEM, focal and periodic EEG 
changes, abnormal MRI and CSF predisposed to a more lengthy course of 
mechanical ventilation.  
11. Due to severe intracranial hypertension 4 patients underwent surgical 
decompression , which is not routinely applied in encephalitis. One patient 
could be saved by it, thus we recommend immediately performing it in all 
cases of intracranial hypertension not responding to conservative treatment, 
even in patients with encephalitis.  
12. Morbidity:   
12.1. In cases of ADEM, severely disturbed consciousness, seizures, severe 
dysfunction, focal, paroxysmal or periodic EEG changes, abnormal MRI 
made sequelae more likely.  
12.2. The most severe sequelae occurred more frequently following 
encephalitis in infancy.  
12.3. All patients with encephalitis due to Mycoplasma pneumoniae 
recovered completely.  
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12.4. The latency of postencephalitic epilepsy was inversely related to its 
severity. This has been previously established by only two groups, based 
upon experiences with markedly smaller number of patients.  
12.5. Patients with brainstem symptoms had a lower risk of PE.  
13. Among the most important predictors of unfavourable outco me 
(permanent sequelae and death) we found lower peripheral blood WBC, 
that has not yet been emphasized by others.  
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